Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
FINDER-AF
Finger Worn Detection Via Electrocardiographic Ring of Atrial Fibrillation and ECG Waveform Analysis (FINDER-AF)
1 other identifier
observational
232
1 country
3
Brief Summary
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2025
CompletedFirst Submitted
Initial submission to the registry
March 18, 2025
CompletedFirst Posted
Study publicly available on registry
March 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedMarch 27, 2025
March 1, 2025
6 months
March 18, 2025
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rhythm classification
Automated rhythm characterization by the ring device as normal sinus rhythm, atrial fibrillation or other.
Baseline
Study Arms (2)
Atrial Fibrillation history
Atrial fibrillation history or active atrial fibrillation
Normal heart rhythm
Patients with no history of prior or active heart arrhythmia
Interventions
Identification of atrial fibrillation by device.
Eligibility Criteria
Patients with or without cardiac arrhythmic history who are 18 years or older and do not have an implanted cardiac device.
You may qualify if:
- years of age or older
You may not qualify if:
- Presence of pacemaker or defibrillator
- Inability to wear a ring in size range available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Everbeatlead
Study Sites (3)
XIMED
La Jolla, California, 92037, United States
Our Lady of Lake Hospital
Baton Rouge, Louisiana, 70808, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Civello, MD
Our Lady of Lake Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2025
First Posted
March 25, 2025
Study Start
September 17, 2024
Primary Completion
March 12, 2025
Study Completion
April 1, 2025
Last Updated
March 27, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
Single study